Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 3
2007 1
2008 1
2012 2
2013 4
2014 4
2015 3
2016 9
2017 6
2018 2
2019 1
2020 5
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
Bioavailability of valsartan oral dosage forms.
Sunkara G, Bende G, Mendonza AE, Solar-Yohay S, Biswal S, Neelakantham S, Wagner R, Flarakos J, Zhang Y, Jarugula V. Sunkara G, et al. Among authors: flarakos j. Clin Pharmacol Drug Dev. 2014 Mar;3(2):132-8. doi: 10.1002/cpdd.56. Epub 2013 Oct 10. Clin Pharmacol Drug Dev. 2014. PMID: 27128457
Development and validation of an LC-MS/MS method for the quantitative analysis of the adenosine A2a receptor antagonist NIR178 and its monohydroxy metabolite in human plasma: Application to clinical pharmacokinetics.
Heudi O, Plaud N, Aumonier C, Wu S, Hatsis P, Hurtado FK, Picard F, Winter S, Flarakos J. Heudi O, et al. Among authors: flarakos j. Biomed Chromatogr. 2020 Oct;34(10):e4909. doi: 10.1002/bmc.4909. Epub 2020 Jul 6. Biomed Chromatogr. 2020. PMID: 32485782 Clinical Trial.
Disposition and metabolism of [¹⁴C]PTZ601 in healthy volunteers.
Flarakos J, Ting LS, Du Y, Stein DS, Reynolds CV, Patel M, Roy S, Mangold JB. Flarakos J, et al. Xenobiotica. 2013 Mar;43(3):283-92. doi: 10.3109/00498254.2012.715696. Epub 2012 Aug 29. Xenobiotica. 2013. PMID: 22931187 Clinical Trial.
38 results